Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +48.99%
#3 DOVU DOVU +48.23%
#4 Velvet Velvet +40.95%
#5 Black Phoenix Black Phoenix +34.26%
#6 Cross Cross +20.75%
#7 Cysic Cysic +18.58%
#8 Perle Perle +18.18%
#9 τemplar τemplar +16.67%
#10 Ribbita by Virtuals Ribbita by Virtuals +15.67%
Coin of the day
Glidr Glidr
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Chimeric Therapeutics Limited Chimeric Therapeutics Limited

Chimeric Therapeutics Limited

CHM
Classifica tra le azioni #38382
Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical... Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical firm dedicated to developing and commercializing a diverse array of cell therapies designed to combat various cancers. Its lead natural killer (NK) cell platform, CHM 0201, is currently undergoing Phase I clinical evaluation for both solid tumors and hematological malignancies. Another key candidate, CHM 1101 (a CLTX CAR T therapy), is also in Phase I trials, specifically targeting recurrent or progressive glioblastoma in patients expressing MMP2+. Beyond these, the company's development pipeline encompasses CHM 0301 for blood cancers; CLTX CAR NK (CHM 1301) and CDH17 CAR NK (CHM 2301) for solid tumors. The CLTX CAR T platform (CHM 1101) is additionally being investigated for melanoma, colorectal, and prostate cancers, while CDH17 CAR T (CHM 2101) is being developed for neuroendocrine, colorectal, pancreatic, and gastric cancers. Chimeric Therapeutics, headquartered in Carlton, Australia, was founded in 2020.
Prezzo delle azioni
$0.02468497
Capitalizzazione di mercato
$1.01M
Variazione (1 giorno)
-12.50%
Variazione (1 anno)
-87.34%
Paese
AU
Scambia Chimeric Therapeutics Limited (CHM)

Categoria

Healthcare
Il prezzo CHM con la capitalizzazione del mercato della B
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
CHM
$0.02468497
Capitalizzazione di mercato di Chimeric Therapeutics Limited(CHM)
Capitalizzazione di mercato: $1.01M
A partire dal August 2026, Chimeric Therapeutics Limited ha una capitalizzazione di mercato pari a $1.01M. Questo rende Chimeric Therapeutics Limited la 38382nd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Chimeric Therapeutics Limited dal 2021 al 2026
CHM in paragone con la classifica dei più popolari stocks
Il prezzo per CHM Attivo B Capitalizzazione del mercato a B Risultati
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$132,828 $1.01M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +538,091,748.10%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$109,440 $1.01M
Apple Inc. Apple Inc.
AAPL
$4.492T +443,347,174.13%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$101,475 $1.01M
Alphabet Inc. Alphabet Inc.
GOOG
$4.165T +411,081,281.86%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$89,569.39 $1.01M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +362,849,843.20%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$69,023.47 $1.01M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +279,617,311.27%